On April 17, 2020 partner Benjamin Greenblum published an article titled "Courts Grappling with Antitrust Challenges to Orange Book Listings" in Law360’s Expert Analysis series. The article discusses the potential risk of antitrust liability for pharmaceutical companies listing patents in the FDA’s Orange Book and how the courts are addressing these issues.
Click here to read the article.
Email Williams & Connolly LLP Office
Please be aware that we cannot represent you until we have confirmed that doing so will not create a conflict of interests and we have agreed to the representation. Therefore, please do not send us any information about any matter until you receive a written statement from us that we have agreed to represent you (an “engagement letter”). Sending information to Williams & Connolly LLP will not create, and receipt does not constitute, an attorney-client relationship. Unless you have executed an engagement letter, Williams & Connolly’s receipt of information from you about a matter will not prevent the law firm from representing someone else who is adverse to you in the same matter, and any information that you provide may not be treated as privileged or confidential.
The best way for you to inquire regarding possible representation is to telephone one of our attorneys. Thank you for your interest in Williams & Connolly LLP.
Please click "Accept" to confirm that you agree to these terms.